Latest Insurance News

Bridge SaaS Limited reports a 7% increase in NDIS participant numbers through its majority-owned Brightside, while advancing regional expansion and targeting cash flow positivity by refining operational efficiencies.

State Gas Limited advances its Rolleston West Project with successful drilling of two vertical wells confirming coal and gas continuity, aiming to establish a maiden 2P reserve. Concurrently, the company expands its high density natural gas supply, targeting significant revenue growth through a six-truck dual fuel trial.

Otto Energy reported steady revenue of US$5.2 million in Q1 2025 despite a 9% production decline, offset by higher commodity prices and a significant insurance claim. The company also strengthened its cash position and reduced operating costs.

Mesoblast has commercially launched Ryoncil in the US for pediatric acute GVHD, backed by a strong cash position and advancing multiple cell therapy programs.

AUCyber Limited reported a decline in Q3 FY25 cash receipts amid strategic rationalisation and a completed takeover by 5G Networks Limited, which now controls nearly 90% of shares. The company also refreshed its leadership and raised $2.75 million through an entitlement offer.

Control Bionics reports its strongest US revenue in years alongside Australia’s best quarter since 2022, propelled by new product launches and strategic investments.

Invert Graphite has lodged a prospectus to raise up to A$3.5 million through a share offer priced at A$0.03 each, while advancing its acquisition of a Tanzanian critical minerals project. The company reported no exploration activity this quarter and incurred operating losses, reflecting a transitional phase ahead of relisting.

Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.

Emyria Limited reports sustained clinical success in its PTSD program, launches a new treatment-resistant depression therapy, and opens a second Empax Centre to meet growing demand. The company is progressing funding discussions with health insurers and government bodies to support expansion.

Vital Metals is nearing completion of a pivotal Scoping Study for its Tardiff deposit in Canada, while spearheading a new Canadian rare earths consortium and securing fresh funding to support its development ambitions.

FINEOS Corporation Holdings PLC reported a robust first quarter for FY25, with cash balances soaring to €35.4 million and customer receipts up 40% year-on-year, underpinned by successful platform deployments and a healthy sales pipeline in North America.

Aroa Biosurgery reports a second consecutive quarter of positive operating cash flow and record sales for its Myriad product line, while maintaining full-year FY25 revenue and EBITDA guidance.